Operable bulky stages IB and II squamous-cell carcinomas of uterine cervix treated with combined primary radiation therapy and surgery;Carcinomes épidermoïdes du col utérin opérables de stades IB et II de gros volume traités par irradiation première et chirurgie

Cancer/Radiotherapie

Volumn 6, Issue 2, 2002, Pages 85-98

  Bernard, A ^a   Touboul, E ^a   Lefranc, J P ^b   Deniaud Alexandre, E ^a   Genestie, C ^b   Uzan, S ^a   Blondon, J ^b  

^a HÔPITAL TENON   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Bulky cervical carcinomas; Complications; Prognostic factors; Radiation therapy; Surgery

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CYSTOVAGINAL FISTULA; FEMALE; FEMUR HEAD NECROSIS; HUMAN; INTESTINE OBSTRUCTION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PELVIS LYMPHADENECTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; RECURRENCE RISK; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; URETER OBSTRUCTION; UTERINE CERVIX CARCINOMA;

EID: 18244412716     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(02)00148-8     Document Type: Article

References (89)

1. Radical hysterectomy in the treatment of patients with bulky early stage carcinoma of the cervix uteri
2. Non-randomized comparative study of irradiation alone or in combination with surgery in stage Ib, IIa and « proximal » IIb carcinoma of the cervix
3. Carcinoma of the intact uterine cervix treated with radiotherapy alone: A French cooperative study: Update and multivariate analysis of prognostic factors
4. Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: Baseline results to compare new strategies
5. Bulky stage IB cervical carcinoma managed by primary radical hysterectomy followed by tailored radiotherapy
6. Incorporating biologic measurements (SF2, CFE) into a tumor control probability model increases their prognostic significance: A study in cervical carcinoma treated with radiation therapy
7. La plésiocuriethérapie des cancers du vagin par moulage plastique avec l'iridium 192 (préparation non radioactive)
8. A glossary for reporting complications of treatment in gynecological cancers
9. Prophylactic irradiation of para-aortic lymph nodes in carcinoma of uterine cervix. A prospective randomized study
10. Technically accurate intracavitary insertions improve pelvic control and survival among patients with locally advanced carcinoma of the uterine cervix
11. Pretreatment surgical staging of patients with cervical carcinoma. The case for lymph node debulking
12. Regression models and life table
13. Radical hysterectomy as therapy for early carcinoma of the cervix
14. New gynecologic cancer staging
15. Incidence of severe chronic eleitis after abdominal and/or pelvic external irradiation with high energy photon beams
16. Radiosensitivity testing of primary cervical carcinoma: Evaluation of intra- and inter-tumour heterogeneity
17. High-dose-rate brachytherapy for carcinoma of the cervix: High tech or high risk?
18. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix
19. Dosimetric methods in the optimization of radiotherapy for carcinoma of the uterine cervix
20. Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: Does the new staging system predict morbidity and survival?
21. Severe radiation morbidity in carcinoma of the cervix: Impact of pretherapy surgical staging and previous surgery
22. The effect of treatment duration in the local control of the cervix cancer
23. Prognostic factors in patients with cervix cancer treated by radiation therapy: Results of a multiple regression analysis
24. Combined radiation therapy and extrafacial hysterectomy in the treatment of stage IB barrel-shaped cervical cancer
25. Combined radiotherapy and surgery: Local control and complications in early carcinoma of the uterine cervix - The Villejuif experience, 1975-1984
26. Overall treatment time in advanced cervical carcinomas: A critical parameter in treatment outcome
27. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10
28. Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix stage 1B and IIA treated with preoperative irradiation and surgery
29. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix
30. Resection of bulky positive lymph nodes in patients with cervical carcinoma
31. The need for complex technology in radiation oncology. Correlations of facility characteristics and structure with outcome
32. Is prophylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC Radiotherapy Group
33. Radiotherapy alone in carcinoma of the intact uterine cervix according to GH Fletcher guidelines: A French cooperative study of 1 383 cases
34. Nonparametric estimation from incomplete observations
35. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage Ib cervical carcinoma
36. Conventional four-field pelvic radiotherapy technique without CT treatment planning in cancer of the cervix: Potential geographic miss
37. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases. An analysis of 891 cases
38. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: A final report of the 1973 and 1978 patterns of care studies
39. Influence of age, prior abdominal surgery, fraction size, and dose on the complications after radiation therapy for squamous cell cancer of the uterine cervix: A patterns of care study
40. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer
41. Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: A prospective randomized study
42. LENT-SOMA Scales for all anatomic sites
43. FIGO IIIB squamous cell carcinoma of the cervix: An analysis of prognostic factors emphasizing the balance between external beam and intra cavitary radiation therapy
44. Stage IB or IIA-B carcinoma of the intact uterine cervix treated with irradiation: A multivariate analysis
45. Chi-square with one degree of freedom: Extensions of the Mantel-Haenszel procedure
46. Dose-response and failure pattern for bulky or Barrel-shaped stage IB cervical cancer treated by combined photon irradiation and extrafacial hysterectomy
47. Cervical cancer: Application of MR imaging in radiation therapy
48. Stage IB or IIA-B carcinoma of the intact uterine cervix ≥ 6 cm in diameter: Is adjuvant extrafacial hysterectomy beneficial?
49. Lymphatic spread of stage IB/II cervical carcinoma: Anatomy and surgical implications
50. Interest of para-aortic lymphadenectomy in patients with stage IB and II cervical carcinoma
51. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
52. The American brachytherapy practice for carcinoma of the cervix in the United States
53. Increased morbidity following the introduction of remote afterloading, with increased dose rate, for cancer of the cervix
54. Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation
55. Low dose rate versus high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: A clinical trial
56. Impact of dose in outcome of irradiation alone in carcinoma of the uterine cervix: Analysis of two different methods
57. Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: Update of a non randomized comparison
58. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy
59. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix
60. Radiation therapy morbidity in carcinoma of the uterine cervix: Dosimetric and clinical correlation
61. Étude statistique d'une série de 672 carcinomes du col utérin. Résultats et complications selon l'âge et les modalités de traitement
62. The adverse effect of treatment prolongation in cervical carcinoma
63. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
64. Five classes of Extended Hysterectomy for women with cervical cancer
65. Extraperitoneal endosurgical aortic and common iliac dissection in the staging of bulky or advanced cervical carcinoma
66. Uenvahissement ganglionnaire pelvien dans les cancers du col utérin
67. Radical hysterectomy and tailored postoperative radiation therapy in the management of bulky stage IB cervical cancer
68. Evaluation of late morbidity in patients with carcinoma of the uterine cervix following a dose rate change
69. Limitations of adjunctive surgery in carcinoma of the cervix
70. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIb and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20
71. Sagittal magnetic resonance imaging in the design of lateral radiation treatment portals for patients with locally advanced squamous cancer of the cervix
72. Three-dimensional treatment planning of intra cavitary gynecologic implants: Analysis of ten cases and implications for dose specification
73. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group study
74. Treatment of carcinoma of the uterine cervix by remotely controlled afterloading intracavitary radiotherapy with high dose-rate: A comparative study with a low dose-rate system
75. Analysis of complications of cervix carcinoma treated by radiotherapy using the Franco-Italian glossory
76. Carcinoma of the cervix treated with radiation therapy I. A multivariate analysis of prognostic variables in the Gynecologic Oncology Group
77. Magnetic resonance imaging in the treatment planning of radiation therapy in carcinoma of the cervix treated with the four-field pelvic technique
78. Bulky endocervical carcinoma: A 23-year experience
79. Tumour proliferation and apoptosis in human cervix carcinoma II: Correlations with clinical outcome
80. Treatment of cancer of the cervix uteri. A revised « Manchester Method »
81. Preoperative radiation therapy and surgery in the treatment of « Bulky » squamous cell carcinoma of the uterine cervix (stage Ib, IIa, and IIb operable tumors)
82. Carcinomes épidermoïdes du col utérin stade I et II de gros volume traités par radiothérapie première et chirurgie
83. Cervical carcinoma metastatic to para-aortic nodes: Extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: A Gynecologic Oncology Group study
84. Extraperitoneal laparoscopic paraaortic lymph node dissection
85. Carcinoma of the intact uterine cervix, stage IB-IIA-B ≥ 6 cm in diameter: Irradiation alone vs preoperative irradiation and surgery
86. Extraperitoneal versus transperitoneal selective paraaortic lymphadenectomy and radiation therapy in pretreatment surgical staging of advanced cervical carcinoma (a Gynecologic Oncology Group study)
87. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma
88. Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix